Jingyue Biotechnology's Roy's Vaccine ADR1 Receives Approval Number A00265
Jingyue Biotechnology has developed Roy's vaccine ADR1, which has received approval from Taiwan's Ministry of Health and Welfare under construction site A00265.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
BCC News Taiwan
“唐梅勒最重要的灵魂就是我们京月研发的罗伊氏疫苗ADR1。大家都知道，这不是普通的疫苗，是拿到卫福部建设地A00265号。”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade